News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Christina Izzo

Articles by Christina Izzo

Ramucirumab Combination Improves OS and PFS in NSCLC

ByChristina Izzo

March 20th 2014

Melanoma Combination Granted Priority Review Designation by FDA

ByChristina Izzo

October 22nd 2013

Latest Updated Articles

Melanoma Combination Granted Priority Review Designation by FDA
Published: October 22nd 2013 | Updated:
Ramucirumab Combination Improves OS and PFS in NSCLC
Published: March 20th 2014 | Updated:

Trending on AJMC

FDA Approves Oral Semaglutide as First GLP-1 Pill for Weight Loss

Top 5 Most-Read CLL Articles of 2025

Top 5 Most-Read "5 Things" Articles of 2025

Visibility, Not Lesion Burden, Drives Distress in Alopecia Areata

Evidence Suggests Bidirectional Risk Between Ovarian, Colorectal Cancers

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.